The Tayside Medicines Monitoring Unit (MEMO): A record-linkage system for pharmacovigilance

J. M M Evans, D. G. McDevitt, T. M. MacDonald

    Research output: Contribution to journalArticlepeer-review

    70 Citations (Scopus)


    Post marketing surveillance of drugs is important. The Medicines Monitoring Unit (MEMO) has developed an automated database based on record-linkage techniques to conduct post-marketing drug safety studies. MEMO has access to data for the 400,000 residents of Tayside, Scotland, which are all indexed by the Community Health Number (CHNo), a unique patient identifier. Dispensed prescribing records can be linked to hospitalization records, via the CHNo, to conduct drug utilization studies, case-control studies and cohort studies. Such studies are described and future developments in MEMO are also discussed.

    Original languageEnglish
    Pages (from-to)177-184
    Number of pages8
    JournalPharmaceutical Medicine
    Issue number3
    Publication statusPublished - 1 Dec 1995


    • Medicines Monitoring Unit
    • MEMO
    • Pharmacovigilance
    • Record-linkage

    ASJC Scopus subject areas

    • Pharmacology


    Dive into the research topics of 'The Tayside Medicines Monitoring Unit (MEMO): A record-linkage system for pharmacovigilance'. Together they form a unique fingerprint.

    Cite this